Eli Lilly and Company (LLY)

NYSE HEALTHCARE
$1,098.57 -1.21% RSI 55 Neutral Add Alert

Moving Averages

SMA 50
$1,010.25
Price above
SMA 200
$954.13
Price above
EMA 20
$1,097.63
Price above

Company Profile

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$1.04T
P/E Ratio
41.19
EPS
$28.18
Beta
0.517
Dividend Yield
0.55%
52-Week High
$1182.73
52-Week Low
$619.4

Insider Transactions

ExecutiveTitleActionSharesDate
FYRWALD, J ERIKDirectorBuy82026-06-15
LUCIANO, JUAN RDirectorBuy142026-06-15
ALVAREZ, RALPHDirectorBuy102026-06-15
Continue with Google

Latest News

Earnings Call Transcript

Eli Lilly and Company Q1 2026 — Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2026 Earnings Conference Call. I would now like to turn the conference over to your host, Mike Czapar, Senior Vice President of Investor Relations. Please go ahead.…

Continue with Google

Options Chain

TypeStrikeExpiryVolumeOpen Interest
Call$1,100.002026-06-181,3041,475
Put$560.002026-07-10877121
Call$1,105.002026-06-1865335
Continue with Google

Similar stocks in DRUG MANUFACTURERS - GENERAL

PFE
Pfizer Inc
RSI 39.0
JNJ
Johnson & Johnson
RSI 45.0
BMY
Bristol-Myers Squibb Company
RSI 38.0
MRK
Merck & Co Inc
RSI 45.0
NVO
Novo Nordisk
RSI 49.0
ABBV
Abbvie Inc
RSI 48.0
GILD
Gilead Sciences Inc
RSI 40.0
AMGN
AMGEN Inc
RSI 47.0
GSK
GSK Plc
RSI 45.0
OGN
Organon & Company
RSI 72.0

Data last updated: June 21, 2026 at 10:39 PM EDT

Track LLY for free

Get e-mail RSI alerts when Eli Lilly and Company enters oversold or overbought territory. Free forever.

Add Alert